KHN’s ‘What the Health?’: Dealing With Drug Prices

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
http://dlvr.it/SH4V25

Comments

Popular posts from this blog

Bustos on Bloomberg TV: In Last Two Weeks, “Price of Gas Has Gone Down Forty Cents”

Bustos Announces More Than $7.1 Million in Federal Funding for Peoria Head Start